209 related articles for article (PubMed ID: 26561062)
21. Parkinson's disease: oxidative stress and therapeutic approaches.
Surendran S; Rajasankar S
Neurol Sci; 2010 Oct; 31(5):531-40. PubMed ID: 20221655
[TBL] [Abstract][Full Text] [Related]
22. The Chinese herbal formula Liuwei dihuang protects dopaminergic neurons against Parkinson's toxin through enhancing antioxidative defense and preventing apoptotic death.
Tseng YT; Chang FR; Lo YC
Phytomedicine; 2014 Apr; 21(5):724-33. PubMed ID: 24411708
[TBL] [Abstract][Full Text] [Related]
23. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
Perfeito R; Cunha-Oliveira T; Rego AC
Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
[TBL] [Abstract][Full Text] [Related]
24. Paeonolum protects against MPP(+)-induced neurotoxicity in zebrafish and PC12 cells.
Lu XL; Lin YH; Wu Q; Su FJ; Ye CH; Shi L; He BX; Huang FW; Pei Z; Yao XL
BMC Complement Altern Med; 2015 Apr; 15():137. PubMed ID: 25925762
[TBL] [Abstract][Full Text] [Related]
25. Melatonin and Parkinson's disease.
Mayo JC; Sainz RM; Tan DX; Antolín I; Rodríguez C; Reiter RJ
Endocrine; 2005 Jul; 27(2):169-78. PubMed ID: 16217130
[TBL] [Abstract][Full Text] [Related]
26. Oxidative stress and neuroinflammation in the story of Parkinson's disease: Could targeting these pathways write a good ending?
Hassanzadeh K; Rahimmi A
J Cell Physiol; 2018 Jan; 234(1):23-32. PubMed ID: 30078201
[TBL] [Abstract][Full Text] [Related]
27. Exploring the Efficient Natural Products for the Therapy of Parkinson's Disease
Zhang W; Ju Y; Ren Y; Miao Y; Wang Y
Curr Drug Targets; 2024; 25(2):77-93. PubMed ID: 38213160
[TBL] [Abstract][Full Text] [Related]
28. Pre-clinical therapeutic development of a series of metalloporphyrins for Parkinson's disease.
Liang LP; Huang J; Fulton R; Pearson-Smith JN; Day BJ; Patel M
Toxicol Appl Pharmacol; 2017 Jul; 326():34-42. PubMed ID: 28400118
[TBL] [Abstract][Full Text] [Related]
29. The potential role of herbal products in the treatment of Parkinson's disease.
Amro MS; Teoh SL; Norzana AG; Srijit D
Clin Ter; 2018; 169(1):e23-e33. PubMed ID: 29446788
[TBL] [Abstract][Full Text] [Related]
30. Secretome released from hydrogel-embedded adipose mesenchymal stem cells protects against the Parkinson's disease related toxin 6-hydroxydopamine.
Chierchia A; Chirico N; Boeri L; Raimondi I; Riva GA; Raimondi MT; Tunesi M; Giordano C; Forloni G; Albani D
Eur J Pharm Biopharm; 2017 Dec; 121():113-120. PubMed ID: 28965958
[TBL] [Abstract][Full Text] [Related]
31. Targeting urate to reduce oxidative stress in Parkinson disease.
Crotty GF; Ascherio A; Schwarzschild MA
Exp Neurol; 2017 Dec; 298(Pt B):210-224. PubMed ID: 28622913
[TBL] [Abstract][Full Text] [Related]
32. Preclinical and Potential Applications of Common Western Herbal Supplements as Complementary Treatment in Parkinson's Disease.
Morgan LA; Grundmann O
J Diet Suppl; 2017 Jul; 14(4):453-466. PubMed ID: 28095073
[TBL] [Abstract][Full Text] [Related]
33. Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson's disease.
Yoritaka A; Kawajiri S; Yamamoto Y; Nakahara T; Ando M; Hashimoto K; Nagase M; Saito Y; Hattori N
Parkinsonism Relat Disord; 2015 Aug; 21(8):911-6. PubMed ID: 26054881
[TBL] [Abstract][Full Text] [Related]
34. Protective effects of Chunghyuldan against ROS-mediated neuronal cell death in models of Parkinson's disease.
Kim HG; Ju MS; Kim DH; Hong J; Cho SH; Cho KH; Park W; Lee EH; Kim SY; Oh MS
Basic Clin Pharmacol Toxicol; 2010 Dec; 107(6):958-64. PubMed ID: 20629656
[TBL] [Abstract][Full Text] [Related]
35. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
[TBL] [Abstract][Full Text] [Related]
36. Oxidative Stress, Pro-Inflammatory Cytokines, and Antioxidants Regulate Expression Levels of MicroRNAs in Parkinson's Disease.
Prasad KN
Curr Aging Sci; 2017; 10(3):177-184. PubMed ID: 28042771
[TBL] [Abstract][Full Text] [Related]
37. Protective effect of hesperidin in a model of Parkinson's disease induced by 6-hydroxydopamine in aged mice.
Antunes MS; Goes AT; Boeira SP; Prigol M; Jesse CR
Nutrition; 2014; 30(11-12):1415-22. PubMed ID: 25280422
[TBL] [Abstract][Full Text] [Related]
38. Dopamine D2 receptor-mediated antioxidant and neuroprotective effects of ropinirole, a dopamine agonist.
Iida M; Miyazaki I; Tanaka K; Kabuto H; Iwata-Ichikawa E; Ogawa N
Brain Res; 1999 Aug; 838(1-2):51-9. PubMed ID: 10446316
[TBL] [Abstract][Full Text] [Related]
39. Mitochondria-targeted peptide antioxidants: novel neuroprotective agents.
Szeto HH
AAPS J; 2006 Aug; 8(3):E521-31. PubMed ID: 17025271
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the neuroprotective potential of Mucuna pruriens seed extract with estrogen in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mice model.
Yadav SK; Prakash J; Chouhan S; Westfall S; Verma M; Singh TD; Singh SP
Neurochem Int; 2014 Jan; 65():1-13. PubMed ID: 24333323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
